1. Prediction of macrovascular events and mortality in people with type 2 diabetes using dynamic modelling of systolic blood pressure: the Hoorn Diabetes Care System cohort

   Nijpels, G., Yauw, J., Feenstra, T., Baan, C., Beulens, J., Elders, P., Herings, R., Moons, K., Slieker, R., Peelen, L. & van der Heijden, A., Sep-2019, In : Diabetologia. 62, p. S573-S573 1 p.

   Research output: Contribution to journal › Meeting Abstract › Academic

2. Population based diabetes screening is associated with less insulin therapy compared to usual care

   Vos, R. C., den Ouden, H., Daamen, L. A., Bilo, H. J. G., Denig, P. & Rutten, G. E. H., Oct-2018, In : Diabetologia. 61, p. S424 1 p.

   Research output: Contribution to journal › Meeting Abstract › Academic

3. Prediction models for the risk of diabetic foot in people with type 2 diabetes: a systematic review and external validation study

   Beulens, J. W., Yauw, J. S., Peelen, L. M., Feenstra, T. L., Moons, K. G., Slieker, R. C., Herings, R. M., Elders, P. J., Nijpels, G. & van der Heijden, A. A., Sep-2019, In : Diabetologia. 62, p. S459-S460 2 p.

   Research output: Contribution to journal › Meeting Abstract › Academic

4. Canagliflozin and fracture risk in individuals with type 2 diabetes: results from the CANVAS Program

   Zhou, Z., Jardine, M., Perkovic, V., Matthews, D. R., Mahaffey, K. W., de Zeeuw, D., Fulcher, G., Desai, M., Oh, R., Simpson, R., Watts, N. B. & Neal, B., Oct-2019, In : Diabetologia. 62, 10, p. 1854-1867 14 p.

   Research output: Contribution to journal › Article › Academic › peer-review

5. Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney disease

   Heerspink, H. J. L., Perco, P., Mulder, S., Leierer, J., Hansen, M. K., Heinzel, A. & Mayer, G., Jul-2019, In : Diabetologia. 62, 7, p. 1154-1166 13 p.

   Research output: Contribution to journal › Article › Academic › peer-review

View all (202) »